HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

A V Schally Selected Research

vapreotide

10/2010The inhibitory effect of a novel cytotoxic somatostatin analogue AN-162 on experimental glioblastoma.
5/2001Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cell line xenografted into nude mice.
10/2000Human ovarian cancers express somatostatin receptors.
8/2000Regulation of targeted chemotherapy with cytotoxic lutenizing hormone-releasing hormone analogue by epidermal growth factor.
7/2000High expression of somatostatin receptors and messenger ribonucleic acid for its receptor subtypes in organ-confined and locally advanced human prostate cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


A V Schally Research Topics

Disease

55Neoplasms (Cancer)
11/2014 - 01/2000
17Carcinoma (Carcinomatosis)
02/2004 - 01/2000
12Ovarian Neoplasms (Ovarian Cancer)
08/2012 - 05/2000
11Prostatic Neoplasms (Prostate Cancer)
11/2014 - 02/2000
8Neoplasm Metastasis (Metastasis)
01/2006 - 06/2000
8Pancreatic Neoplasms (Pancreatic Cancer)
05/2004 - 01/2000
5Breast Neoplasms (Breast Cancer)
07/2013 - 03/2000
4Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
11/2014 - 07/2000
4Glioblastoma (Glioblastoma Multiforme)
10/2010 - 02/2000
4Renal Cell Carcinoma (Grawitz Tumor)
01/2006 - 06/2000
2Pheochromocytoma
05/2013 - 09/2009
2Endometrial Neoplasms (Endometrial Cancer)
08/2012 - 11/2000
2Brain Neoplasms (Brain Tumor)
10/2010 - 02/2000
2Endometriosis (Adenomyosis)
01/2010 - 07/2000
2Leiomyoma (Uterine Fibroids)
01/2010 - 07/2000
2Glioma (Gliomas)
04/2002 - 05/2000
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2001 - 12/2000
2Adenocarcinoma
03/2000 - 02/2000
1Alzheimer Disease (Alzheimer's Disease)
01/2010
1Adrenal Cortex Neoplasms (Adrenocortical Cancer)
09/2009
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2008
1Melanoma (Melanoma, Malignant)
01/2006
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2006

Drug/Important Bio-Agent (IBA)

26Messenger RNA (mRNA)IBA
07/2013 - 01/2000
25Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA
07/2013 - 01/2000
22Gonadotropin-Releasing Hormone (GnRH)FDA Link
05/2013 - 02/2000
19Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
05/2013 - 02/2000
14BombesinIBA
05/2008 - 03/2000
11AN 204 (AN 201)IBA
05/2008 - 02/2000
10somatotropin releasing hormone receptorIBA
07/2013 - 09/2000
10HormonesIBA
05/2013 - 02/2000
10Gastrin-Releasing PeptideIBA
06/2005 - 03/2000
10Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2004 - 03/2000
10Insulin-Like Growth Factor I (IGF-1)IBA
05/2004 - 01/2000
9LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
05/2013 - 02/2000
8AN 238IBA
05/2013 - 02/2000
8Doxorubicin (Adriamycin)FDA LinkGeneric
10/2010 - 02/2000
8PeptidesIBA
05/2008 - 03/2000
8Somatostatin Receptors (Somatostatin Receptor)IBA
01/2005 - 06/2000
8Insulin-Like Growth Factor II (Somatomedin A)IBA
05/2004 - 01/2000
7JV 1-36IBA
11/2001 - 03/2000
6cetrorelix (Cetrotide)FDA Link
05/2013 - 05/2000
6MZ 5-156IBA
06/2008 - 01/2000
6Estrogens (Estrogen)FDA Link
10/2001 - 02/2000
5T 107IBA
05/2013 - 08/2000
5vapreotideIBA
10/2010 - 07/2000
5Epidermal Growth Factor (EGF)IBA
05/2004 - 03/2000
5JV 1-38IBA
02/2004 - 07/2000
4RNA (Ribonucleic Acid)IBA
06/2008 - 02/2000
4Bombesin Receptors (Bombesin Receptor)IBA
06/2005 - 03/2000
4Hca(6)-Leu(13)-psi(CH2N)-Tac(14)- bombesin(6-14)IBA
01/2004 - 03/2000
4Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)- bombesin (6-14)IBA
01/2004 - 03/2000
4Somatomedins (Somatomedin)IBA
01/2004 - 01/2000
4AN 207IBA
01/2002 - 02/2000
4Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
11/2001 - 06/2000
3PhAcTyr(1)- Arg(2)- P(H)e(4- CL)(6)- Ala(8)- Tyr(Me)(10)- His(11)- Abu(15)- His(20)- Nle(27)- Arg(28)- HLCr(29)- GHRH(1-29)NH2IBA
07/2013 - 06/2008
3NeuropeptidesIBA
05/2013 - 07/2000
3Peptide Receptors (Peptide Receptor)IBA
05/2013 - 05/2004
3MZ 4-71IBA
09/2009 - 01/2000
3Insulin (Novolin)FDA Link
05/2004 - 05/2000
3RC 121IBA
09/2001 - 02/2000
3harpin (messenger)IBA
05/2001 - 02/2000
3bombesin receptor subtype 3IBA
11/2000 - 03/2000
3Membrane Proteins (Integral Membrane Proteins)IBA
09/2000 - 02/2000
2Testosterone (Sustanon)FDA Link
11/2014 - 02/2000
2AndrogensIBA
11/2014 - 08/2001
2Conditioned Culture MediaIBA
01/2014 - 05/2000
2CytotoxinsIBA
01/2005 - 01/2001
2pentetreotide (OctreoScan)FDA Link
01/2005 - 01/2001
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2004 - 09/2001
2AN 215IBA
04/2002 - 11/2000
2Epidermal Growth Factor Receptor (EGF Receptor)IBA
09/2001 - 04/2001
2Carboxylic Ester HydrolasesIBA
09/2001 - 11/2000
2Ovarian epithelial cancerIBA
10/2000 - 06/2000
2Proteins (Proteins, Gene)IBA
09/2000 - 02/2000
1PPAR gammaIBA
11/2014
1Adenosine Triphosphate (ATP)IBA
11/2014
1Glucose (Dextrose)FDA LinkGeneric
11/2014
1Carbon MonoxideIBA
11/2014
1AMP-Activated Protein KinasesIBA
11/2014
1Phosphotransferases (Kinase)IBA
11/2014
1docetaxel (Taxotere)FDA Link
07/2013
1Har(29)- Arg(28) Nle(27) Orn(21) His(20) Orn(12,) Abu(15) His(11) Tyr(Me)(10) Har(9) Ala(8) Fpa(5,6) Arg(2) (PhAc-Ada)(0)-Tyr(1) GHRH(1-29)NH2IBA
05/2013
1somatostatin receptor 2IBA
05/2013
1LH Receptors (LH Receptor)IBA
08/2012
1MZ-J-7-118IBA
10/2011
1(N-acetyl-tyr1,D-arg2)fragment 1-29 amideIBA
10/2011
1Neuropeptide Receptors (Neuropeptide Receptor)IBA
09/2009
1Nerve Growth Factor (NGF)IBA
09/2009
1Somatotropin Receptors (Growth Hormone Receptor)IBA
09/2009
1Growth Hormone (Somatotropin)IBA
09/2006
1RadiopharmaceuticalsIBA
01/2005
1Peptide Hormones (Polypeptide Hormones)IBA
01/2005

Therapy/Procedure

11Drug Therapy (Chemotherapy)
08/2012 - 02/2000
8Heterologous Transplantation (Xenotransplantation)
07/2013 - 03/2000
4Injections
03/2001 - 02/2000
3Aftercare (After-Treatment)
11/2000 - 02/2000
2Prostatectomy (Retropubic Prostatectomy)
07/2000 - 02/2000
1Individualized Medicine
08/2012
1Subcutaneous Injections
10/2011